Biofarm Poland Information

Get Verified Emails For Biofarm Poland
Contact top employees from Biofarm Poland

Summary

Biofarm Poland is a private company. The company currently specializes in the Pharmaceuticals area. The Biofarm Poland annual revenue is estimated at < 1M. To connect with Biofarm Poland employee register on SignalHire.

Organization Website

biofarm.pl

Industries

Headquarters Location

ulica Walbrzyska 13, Poznań, Woj. Wielkopolskie, 60-198 PL

Employees Size

200-500 employees

Specialties

Farmacja, Pharmaceuticals, R&D, Consumer Healthcare, Manufacturers of pharmaceuticals, GMP

Founded

1988

Operating Status

Independent Company

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
See companies people switched from or switched to
Number of employees by department
arrow
Total number all of employee turnover
Discover More
Length of Employment
arrow
Employee tenure at Biofarm Poland shows a diverse range of experience levels:
2% have been with the company for less than 1 year6% for 1–2 years8% for 3–4 years19% for 5–7 years10% for 8–10 years54% have over 11 years of service at Biofarm Poland
Discover More
Ex-employees positions
In Company
In New Company
Sign Up
Contact top employees from Biofarm Poland

FAQ

Biofarm Poland operates in the Pharma industries. More details can be found on the official website: biofarm.pl.
The headquarters of Biofarm Poland are located in Poznań, Poland.
Biofarm Poland currently employs 200-500 people.
Biofarm Poland's revenue is approximately < 1M.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP